Related Experiment Video

Updated: Mar 16, 2026

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

15.7K

Specific Cancer Cytosolic Drug Delivery Triggered by Reactive Oxygen Species-Responsive Micelles

Lu-Yi Yu, Geng-Min Su, Chi-Kang Chen

  • 1School of Pharmacy, China Medical University , Taichung 40402, Taiwan, Republic of China.

Biomacromolecules
|August 19, 2016
PubMed

Insights

This study introduces a novel reactive oxygen species (ROS)-responsive micelle for enhanced cancer therapy. The micelle facilitates endosomal escape in cancer cells, improving drug delivery and targeting specific cancer cells.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Cytosolic drug delivery is crucial for cancer therapy but hindered by inefficient endosomal escape.
  • Existing methods often lack specificity and safety, limiting therapeutic efficacy.

Purpose of the Study:

  • To develop a reactive oxygen species (ROS)-responsive micelle for targeted endosomal escape in cancer cells.
  • To enhance the delivery of acid-intolerant drugs to the cancer cell cytosol, improving selective cytotoxicity.

Main Methods:

  • Synthesized methoxy polyethylene glycol-b-poly(diethyl sulfide) (mPEG-PS) copolymers forming ROS-responsive micelles.
  • Investigated the hydrophobic-hydrophilic conversion of copolymers in response to ROS.
  • Evaluated endosomal escape, drug delivery, and selective cytotoxicity in cancer cells versus normal cells.

Main Results:

  • The mPEG-PS micelles demonstrated ROS-responsive conversion from hydrophobic to hydrophilic.
  • This conversion facilitated specific endosomal escape in cancer cells due to higher ROS levels.
  • Acid-intolerant drugs delivered via these micelles maintained bioactivity, leading to selective cancer cell cytotoxicity.

Conclusions:

  • ROS-responsive micelles offer an efficient and safe strategy for endosomal escape in cancer therapy.
  • This approach enhances the delivery of therapeutic agents to the cancer cell cytosol.
  • The hydrophobic-hydrophilic exchange mechanism holds significant potential for delivering proteins and genes selectively to cancer cells.

More Related Videos

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.3K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

12.1K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K